LENZ Therapeutics Cash Flow Statement (2020-2026) | LENZ

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-130.53M-54.99M-20.94M-27.58M-636.45M-34.23M-28.35M-17.43M-49.79M-53.23M-18.18M-16.14M-10.25M-10.21M-12.65M-15.91M-14.91M-16.70M-35.90M-42.21M
Depreciation and Depletion (Quarter)
0.10M0.20M0.30M0.40M0.60M0.70M0.70M0.70M0.80M0.80M0.10M
Share-based Compensation (Quarter)
2.02M2.37M2.45M3.34M3.36M3.21M3.62M2.85M9.90M0.95M0.27M3.52M-3.62M2.56M-2.56M4.32M
Gains from Investment Securities (Quarter)
0.02M0.02M0.11M-0.27M1.05M
Asset Writedowns and Impairment (Quarter)
7.21M13.35M0.08M
Cash from Restructuring (Quarter)
4.82M-4.77M
Cash from Operations (Quarter)
-13.78M-15.41M-15.59M-21.24M-22.09M-22.22M-22.43M-12.80M-13.52M-13.09M-20.97M-23.94M-15.79M-10.58M-9.08M-16.05M-11.51M-8.59M-33.02M-33.58M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.04M-0.04M0.56M1.12M0.02M0.53M0.51M0.28M0.96M1.36M1.42M1.13M0.89M0.78M0.61M0.32M
Depreciation & Amortization (CF) (Quarter)
0.12M0.20M0.33M0.44M0.58M0.65M0.68M0.00M0.00M0.00M0.00M0.01M0.02M0.01M0.03M0.04M0.02M0.12M0.11M0.11M
Change in Working Capital
Change in Receivables (Quarter)
0.01M
Change in Inventory (Quarter)
3.33M0.89M
Change in Account Payables (Quarter)
3.37M-2.34M0.71M0.58M0.30M0.39M-1.08M-0.57M-1.63M1.97M1.09M-1.27M-2.69M-1.64M1.32M-0.77M-0.86M1.69M-0.16M6.76M
Change in Accured Expenses (Quarter)
0.44M0.94M1.03M-1.67M1.16M1.17M0.45M-0.15M2.98M3.34M1.62M-7.23M-2.25M0.72M1.30M-1.20M2.69M4.46M5.03M-2.11M
Other Working Capital Changes (Quarter)
-0.45M3.64M-1.09M0.07M-0.60M2.96M0.77M-0.43M0.35M-0.41M-0.28M0.52M-0.12M0.28M-0.71M1.00M0.20M-0.09M1.92M0.34M
Investing Activities
Capital Expenditures (Quarter)
0.76M3.64M0.98M3.27M1.39M0.92M1.02M0.01M-0.02M0.32M0.15M0.11M0.09M0.58M-0.79M-0.00M
Sales of Property, Plant and Equipment (Quarter)
0.89M0.68M
Change in Acquisitions & Divestments (Quarter)
90.00M80.25M1.50M21.00M18.00M13.00M22.00M34.90M52.09M58.12M52.41M43.34M49.23M
Cash from Investing Activities (Quarter)
-0.76M-3.64M-0.98M-170.67M-88.22M3.50M13.52M-0.01M-26.88M-17.91M15.17M18.00M-98.39M-62.23M-11.86M18.89M-0.41M-4.33M-89.81M33.16M
Financing Activities
Other financing activities (Quarter)
-0.25M0.01M-0.40M0.64M0.20M0.43M3.41M-3.84M4.04M0.04M0.20M-0.01M0.65M0.01M
Cash from Financing Activities (Quarter)
219.50M31.89M0.31M0.41M-0.06M0.24M83.18M-0.57M-1.91M171.27M-2.14M29.82M0.05M0.04M26.49M0.60M122.61M0.01M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
14.82M82.98M16.98M-82.98M53.39M-3.56M29.77M-0.09M26.10M
Additional items
Change in Cash (Quarter)
204.95M12.84M-16.26M-191.91M-109.90M-18.78M-8.66M70.38M-40.40M-31.57M-7.71M165.33M-116.32M-42.99M-20.89M2.88M14.57M-12.32M-0.22M-0.41M
Free Cash Flow (Quarter)
-14.55M-19.05M-16.57M-24.51M-23.48M-23.13M-23.45M-12.80M-13.51M-13.09M-20.97M-23.94M-15.79M-10.90M-9.23M-16.16M-11.60M-9.17M-32.24M-33.58M
Net Cash Flow (Quarter)
204.95M12.84M-16.26M-191.91M-109.90M-18.78M-8.66M70.38M-40.40M-31.57M-7.71M165.33M-116.32M-42.99M-20.89M2.88M14.57M-12.32M-0.22M-0.41M